NCT01147133 Comparison of Generic and Original Formulation of Clopidogrel Status COMPLETED Phase PHASE4
NCT01137019 Optical Coherence Tomography Assessment of Intimal Tissue and Malapposition Status UNKNOWN Phase PHASE3
NCT01119404 Hämeenlinna Metabolic Syndrome Research Program: Surrogate Indicators for Atherosclerosis Status UNKNOWN Phase N/A
NCT01117506 Coronary Obstruction Detection by Molecular Personalized Gene Expression (Corus CAD or ASGES) Status COMPLETED Phase N/A
NCT01115608 Pharmaceutical Follow-up of Coronary Heart Disease (CHD) Patients Status COMPLETED Phase NA
NCT01097434 Test Safety of Biodegradable and Permanent Limus-Eluting Stents Assessed by Optical Coherence Tomography Status COMPLETED Phase PHASE4
NCT01068106 Test Efficacy of Biodegradable and Permanent Limus-Eluting Stents Status UNKNOWN Phase PHASE4
NCT01064323 Global Vascular Effects of Intermittent Pneumatic Compression-Pilot Study Status COMPLETED Phase NA
NCT01047176 Observational Study to Estimate the Rates of Outcomes in Patients Undergoing Percutaneous Coronary Intervention (PCI) With Drug Eluting Stent (DES) Implantation Who Take Statins Status COMPLETED Phase N/A
NCT01021930 Comparison of Diabetes Mellitus and Non-diabetes Mellitus Patients for DES Surface COVERage by OCT Status TERMINATED Phase NA
NCT00981253 Stress Management and Biomarkers of Risk in Cardiac Rehabilitation Status COMPLETED Phase NA
NCT00973986 Effect of CYP3A Genetic Polymorphisms on the Pharmacokinetics of Atorvastatin Status COMPLETED Phase PHASE1
NCT00960505 Alternate Day Fasting for Weight Loss, Weight Maintenance and Cardio-protection Status COMPLETED Phase NA
NCT00959972 Varenicline Versus Transdermal Nicotine Patch for Smoking Cessation in Patients With Coronary Heart Disease Status COMPLETED Phase PHASE4
NCT00950339 Platelet Inhibitory Effect of Clopidogrel in Patients Treated With Omeprazole, Pantoprazole, or Famotidine Status COMPLETED Phase PHASE4
NCT00947843 Efficacy and Tolerability of Clopidogrel Resinate and Clopidogrel Bisulfate in Patients With Coronary Heart Disease (CHD) or CHD Equivalents Status COMPLETED Phase PHASE4
NCT00939237 Trial of Lycopene/Ateronon for Secondary Prevention of Coronary Heart Disease Status COMPLETED Phase PHASE3